000 | 01177 a2200349 4500 | ||
---|---|---|---|
005 | 20250515132046.0 | ||
264 | 0 | _c20081001 | |
008 | 200810s 0 0 eng d | ||
022 | _a1871-5206 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHénon, Hélène | |
245 | 0 | 0 |
_aPyrrolocarbazoles as checkpoint 1 kinase inhibitors. _h[electronic resource] |
260 |
_bAnti-cancer agents in medicinal chemistry _cAug 2008 |
||
300 |
_a577-97 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Review | ||
650 | 0 | 4 |
_aCarbazoles _xpharmacology |
650 | 0 | 4 | _aCheckpoint Kinase 1 |
650 | 0 | 4 | _aCyclization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xchemical synthesis |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
650 | 0 | 4 |
_aPyrroles _xchemical synthesis |
700 | 1 | _aConchon, Elisabeth | |
700 | 1 | _aHugon, Bernadette | |
700 | 1 | _aMessaoudi, Samir | |
700 | 1 | _aGolsteyn, Roy M | |
700 | 1 | _aPrudhomme, Michelle | |
773 | 0 |
_tAnti-cancer agents in medicinal chemistry _gvol. 8 _gno. 6 _gp. 577-97 |
|
999 |
_c18165103 _d18165103 |